XML 34 R23.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
Schedule of fair value assets measured on recurring basis

The following table presents financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2022 (in thousands):

   Total
Carrying
Value in
Consolidated
Balance
Sheets
   Quoted Prices
in Active
Markets for
Identical
Assets
or Liabilities
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Financial Assets                    
Warrant assets  $2,481   $   $   $2,481 
Marketable investments   585    487        98 
                     
Financial Liabilities                    
Contingent consideration payable  $8,530   $   $   $8,530 

 

The following table presents financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2021 (in thousands):

 

   Total
Carrying
Value in
Consolidated
Balance
Sheets
   Quoted Prices
in Active
Markets for
Identical
Assets
or Liabilities
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Financial Assets                    
Warrant assets  $3,419   $   $   $3,419 
Marketable investments   1,153    1,034        119 
                     
Financial Liabilities                    
Contingent consideration payable  $8,530   $   $   $8,530 
[custom:DisclosureFairValueMeasurementsDetailsAbstract]
   Total
Carrying
Value in
Consolidated
Balance
Sheets
   Quoted Prices
in Active
Markets for
Identical
Assets
or Liabilities
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Financial Assets                    
Warrant assets  $2,481   $   $   $2,481 
Marketable investments   585    487        98 
                     
Financial Liabilities                    
Contingent consideration payable  $8,530   $   $   $8,530 

 

The following table presents financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2021 (in thousands):

 

   Total
Carrying
Value in
Consolidated
Balance
Sheets
   Quoted Prices
in Active
Markets for
Identical
Assets
or Liabilities
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Financial Assets                    
Warrant assets  $3,419   $   $   $3,419 
Marketable investments   1,153    1,034        119 
                     
Financial Liabilities                    
Contingent consideration payable  $8,530   $   $   $8,530 
Schedule of fair value assets measured on recurring basis unobservable input reconciliation

The changes in fair value of the warrant assets during the six months ended June 30, 2022 and 2021 were as follows (in thousands):

 

Fair Value Measurements (Details 2)
                    
June 30, 2022  June 30, 2021
Fair value - December 31, 2021  $3,419   Fair value - December 31, 2020  $2,972 
Issued   227   Issued    
Canceled      Canceled    
Change in fair value   (1,165)  Change in fair value   892 
Fair value - June 30, 2022  $2,481   Fair value - June 30, 2021  $3,864 
Schedule of weighted average assumptions

 

Fair Value Measurements (Details 3)
   June 30, 2022   December 31, 2021 
Dividend rate range        
Risk-free rate range   2.9% to 3.0%   0.97% to 1.44%
Expected life (years) range    2.1 to 6.7     2.6 to 7.0 
Expected volatility range   52.6% to 147.5%    60.2% to 142.0%
Schedule of fair value assets and liabilities measured on nonrecurring basis

Fair Value Measurements (Details 4)
   Total
Carrying
Value in
Consolidated
Balance
Sheets
   Quoted Prices
in Active
Markets for
Identical
Assets
or Liabilities
(Level 1)
   Significant
Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
June 30, 2022  $4,604   $   $   $4,604 
                     
December 31, 2021  $5,612   $   $   $5,612 
Schedule of fair value by balance sheet grouping

The following information is provided to help readers gain an understanding of the relationship between amounts reported in the accompanying unaudited condensed consolidated financial statements and the related market or fair value. The disclosures include financial instruments and derivative financial instruments measured at fair value on a recurring and non-recurring basis.

As of June 30, 2022 (in thousands):

 

   Carrying Value   Fair Value   Level 1   Level 2   Level 3 
Financial Assets                         
Cash and cash equivalents  $55,118   $55,118   $55,118   $   $ 
Finance receivables   174,859    174,859            174,859 
Marketable investments   585    585    487        98 
Warrant assets   2,481    2,481            2,481 
                          
Financial Liabilities                         
Contingent consideration payable  $8,530   $8,530   $   $   $8,530 

 

As of December 31, 2021 (in thousands):

 

   Carrying Value   Fair Value   Level 1   Level 2   Level 3 
Financial Assets                         
Cash and cash equivalents  $42,863   $42,863   $42,863   $   $ 
Finance receivables   181,553    181,553            181,553 
Marketable investments   1,153    1,153    1,034        119 
Warrant assets   3,419    3,419            3,419 
                          
Financial Liabilities                         
Contingent consideration payable  $8,530   $8,530   $   $   $8,530 
[custom:DisclosureFairValueMeasurementsDetails5Abstract]
   Carrying Value   Fair Value   Level 1   Level 2   Level 3 
Financial Assets                         
Cash and cash equivalents  $55,118   $55,118   $55,118   $   $ 
Finance receivables   174,859    174,859            174,859 
Marketable investments   585    585    487        98 
Warrant assets   2,481    2,481            2,481 
                          
Financial Liabilities                         
Contingent consideration payable  $8,530   $8,530   $   $   $8,530 

 

As of December 31, 2021 (in thousands):

 

   Carrying Value   Fair Value   Level 1   Level 2   Level 3 
Financial Assets                         
Cash and cash equivalents  $42,863   $42,863   $42,863   $   $ 
Finance receivables   181,553    181,553            181,553 
Marketable investments   1,153    1,153    1,034        119 
Warrant assets   3,419    3,419            3,419 
                          
Financial Liabilities                         
Contingent consideration payable  $8,530   $8,530   $   $   $8,530